Skip to main content
. 2021 Dec 17;20:237. doi: 10.1186/s12933-021-01431-2

Fig. 1.

Fig. 1

Heatmap depicting log2 transformed levels of metabolites at baseline and after treatment [glimepiride  +  metformin (G) vs. liraglutide  +  metformin (L)]. Groups were further divided into subjects with myocardial infarction (MI) or without MI (C, control)